A detailed study on GHRH receptor Gs-protein coupling kinetics and adenylate cyclase dynamics under somatostatin challenge by CJC-1295.
Receptor Coupling Kinetics: CJC-1295 Interaction with GHRHR and Pituitary Adenylate Cyclase Dynamics
← Back to The GH Pulse Receptor Coupling Kinetics: CJC-1295 Interaction with GHRHR and Pituitary Adenylate Cyclase Dynamics Section 1: Compound Overview (Research Context Only) CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) distinguished by a covalently attached Drug Affinity Complex (DAC) moiety—specifically a maleimido-propionic acid linker. In preclinical models, this modification enables […]
Investigating CJC-1295 GHRHR receptor dynamics and somatotroph secretion kinetics under physiological feedback.
An exploration of CJC-1295 binding kinetics, pituitary GHRHR Gs/cAMP/PKA signaling, and tonic somatotroph stimulation without somatostatin suppression.
A research-context examination of CJC-1295 with DAC pharmacokinetics, including the albumin-binding half-life extension mechanism, prolonged pituitary somatotroph stimulation kinetics, and cumulative IGF-1 axis characterization in pharmacological studies.
Preclinical review of Modified GRF 1-29 pituitary receptor activation and growth hormone transcription kinetics.
A preclinical analysis of CJC-1295 (without DAC) activation of pituitary growth hormone-releasing hormone receptors, cAMP accumulation, and PKA kinetics in somatotroph cell lines.
A detailed scientific overview of the preclinical literature regarding CJC-1295 mechanisms.
This article details the preclinical pharmacokinetics of CJC-1295 with DAC, focusing on spontaneous covalent thioether binding to Cys34 of serum albumin, the resulting extension of plasma half-life from approximately 30 minutes to 6-8 days, and the mechanistic basis for resistance to enzymatic peptidase degradation.
This article investigates CJC-1295 effects on GH pulse architecture and downstream hepatic IGF-1 synthesis, examining JAK2/STAT5 signaling, ternary complex dynamics, and the distinctions between sustained GHRH analog exposure and physiologic pulsatile GH patterns.